The Man with the Golden Gun | |
---|---|
Directed by | Guy Hamilton |
Screenplay by | Richard Maibaum Tom Mankiewicz |
Based on | The Man with the Golden Gun by Ian Fleming |
Produced by | Albert R. Broccoli Harry Saltzman |
Starring | |
Cinematography | Ted Moore Oswald Morris |
Edited by | Raymond Poulton John Shirley |
Music by | John Barry |
Production company | |
Distributed by | United Artists |
Release dates |
|
Running time | 125 minutes |
Countries | United Kingdom[1] United States[2] |
Language | English |
Budget | $7 million |
Box office | $97.6 million |
The Man with the Golden Gun is a 1974 spy film and the ninth in the James Bond series produced by Eon Productions, and the second to star Roger Moore as the fictional MI6 agent James Bond. A loose adaptation of Ian Fleming's posthumously published 1965 novel of the same name, the film has Bond sent after the Solex Agitator, a breakthrough technological solution to contemporary energy shortages, while in a game of cat and mouse facing the assassin Francisco Scaramanga, the "Man with the Golden Gun". The action culminates in a duel between them that settles the fate of the Solex.
The Man with the Golden Gun was the fourth and final film in the series directed by Guy Hamilton. The script was written by Richard Maibaum and Tom Mankiewicz. The film was set in the face of the 1973 energy crisis, a dominant theme in the script; Britain had still not yet fully overcome the crisis when the film was released in December 1974. The film also reflects the then-popular martial arts film craze, with several kung fu scenes and a predominantly Asian location, being set and shot in Thailand, Hong Kong, and Macau. Part of the film is also set in Beirut, Lebanon, but it was not shot there.
The film was met with mixed reviews, and some critics described it as the lowest point in the canon up to that time. Christopher Lee's portrayal of Scaramanga as a villain of similar skill and ability to Bond was praised, but reviewers criticised the film as a whole, particularly its comedic approach and the performances of Moore and Britt Ekland. Whilst profitable, the film is the fourth lowest-grossing in the series, and its relatively modest returns by comparison with those of Live and Let Die (1973) reportedly placed the continuation of the franchise in jeopardy.[3] It was the last Bond film to be co-produced by Albert R. Broccoli and Harry Saltzman, with Saltzman selling his 50% stake in Danjaq, LLC, the parent company of Eon Productions, after the release of the film.